WS.I - Nanomedicine

updated on July 24, 2024


WS.I NANOMEDICINE: FROM RESEARCH TO CLINIC APPLICATION September 12
*Co-organized with:*

WORKSHOP COMMITTEE: Giovanni TOSI, Full Professor, University of Modena & Reggio Emilia, Secretary of European Technology Platform for Nanomedicine Marzia BEDONI, Head of Nanomedicine and Biophotonics Unit in Don Gnocchi Foundation
The session will deal with precision approaches for diagnosis and therapy, as well as gene therapy and drug-based RNA/DNA technologies with applications in cancer, neurological diseases, cardiovascular, rare and genetic diseases.

September 12
09:00 - 10:30 Nanomedicine: Successful Stories WS.I.1 - TT.V.J
Chair: to be defined

WS.I.1.1 TT.V.J.1	Alexandre CECCALDI ETPN Title to be defined
WS.I.1.2 TT.V.J.2	Francesca RE University of Milano Bicocca Title to be defined
WS.I.1.3 TT.V.J.3	Lorena DIEGUEZ Title to be defined
WS.I.1.4 TT.V.J.4	to be defined

11:30 - 13:00 Nanomedicine: Progresses in Nanomedicine WS.I.2 - TT.VI.K
Chair: to be defined

WS.I.2.1 TT.VI.K.1	Fabiana QUAGLIA University of Naples Italian National Center for Gene Therapy
WS.I.2.2 TT.VI.K.2	Valentina CAUDA Polytechnic University of Turin Title to be defined
WS.I.2.3 TT.VI.K.3	to be defined
WS.I.2.4 TT.VI.K.4	Francesca RODÀ University of Modena and Reggio Emilia & Don Gnocchi Foundation mRNA-LNP Ex Vivo Interactions with Human Whole Blood

14:00 - 15:30 Nanomedicine: Innovation WS.I.3 - TT.VII.K
Chair: to be defined

WS.I.3.1 TT.VII.K.1	Sabrina CUOGHI University of Modena and Reggio Emilia Microfluidic and enzyme replacement therapy: PLGA Nanoparticles towards the development of new versatile therapeutic solutions
WS.I.3.2 TT.VII.K.2	to be defined
WS.I.3.3 TT.VII.K.3	Carlotta MARIANECCI Sapienza University of Rome Surfactant based nanobubbles: a combined strategy to enhance brain delivery
WS.I.3.4 TT.VII.K.4	Luigi CALZOLAI ISPRA, JRC European Community Title to be defined